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Abstract:
The SHIP1 gene is a member of the inositol polyphosphate-5-phosphate (INPP5)
and its expressed protein functions as a negative regulator of myeloid cell proliferation,
survival, and migration. Mutations in this gene are associated with various defects and
cancers of the immune system. Previous studies have shown that in response to wound
formation, ship1-deficient zebrafish have increased neutrophil motility while
overexpression of ship1 resulted in decreased neutrophil migration (Lam et al. 2012).
From this research, it is suggested that SHIP1 is a key brake that limits neutrophil
motility through a PI3K signaling-dependent pathway. While the role of SHIP1 during a
wound response has been categorized, its function during a viral infection has been left
uncharacterized. The goal of this present study is to examine the role of ship1 during an
innate immune response to an influenza infection.
Using the zebrafish, Danio rerio, as an in vivo model organism, we hope to reveal
the role of SHIP1 in the innate immune response to a viral infection. It was initially
discovered that upon viral infection, SHIP1 is upregulated, promoting further research
into the role of SHIP1 in the antiviral innate immune response. Morpholino-mediated
SHIP1 knockdown resulted in increased zebrafish survival upon influenza infection,
suggesting that SHIP1 is a critical part of the antiviral immune response. Furthermore,
SHIP1-KD in zebrafish exhibited decreased production of ROS, indicating that SHIP1
plays a role in pathogen killing.
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INTRODUCTION
In order for an organism to defend itself from invading pathogens, the two components of
the immune system: the innate immune system and the adaptive immune system must
both be functioning properly. The innate immune system is the first line of defense and
is present among all organisms, making it the subject of a wide range of research. The
innate immune system is comprised of numerous cells including neutrophils and
macrophages, involved in the phagocytosis and eradication of foreign organisms.
Important steps in microbial killing are migration and phagocytosis, which in neutrophils,
is tightly regulated by the phosphoinositide 3-kinase (PI3K) pathway and the control of
the key signaling molecule, phosphatidylinositol (3,4,5) triphosphate (PIP3).
Viruses are intracellular pathogens that utilize the host cell machinery to replicate viral
particles to cause infection. There are around 200 different viruses that are known to
infect humans but despite their prevalence, vaccines are only available for 15 of the
diseases caused by these viruses, necessitating the need for new antiviral treatments
(Small and Ertl, 2011).
Many viruses have managed to evade microbial killing by disrupting the innate immune
system. Recently, our lab has discovered that a key enzyme in neutrophil migration,
phagocytosis, and microbial killing, SHIP1, is upregulated during a viral infection.
SHIP1 degrades the key signaling molecule, PIP3, to phosphatidylinositol (3,4)
diphosphate (PIP2) in the PI3K pathway, which inhibits important cell functions such as
cell motility, protein synthesis, and actin polymerization. Further research into the role of
SHIP1 during a viral infection could aid in the development of new and effective antiviral
treatments.
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BACKGROUND
Those who are infected with influenza, also known as the flu, experience the symptoms
of fever, cough, congestion, aches, and fatigue. These symptoms are a result of a
systemic viral infection which is acquired primarily through inhalation of airborne
droplets from another infected individual.
Viral infections are common in the human populations. As obligate intracellular
organisms, viruses are able to control and employ the host cell machinery to replicate and
further cause infection. More than 90% of human illnesses may be caused by viral
infections, which are generally systemic (Norkin et al., 2009). To combat viral
infections, organisms utilize both innate and adaptive immune responses. The innate
immune system is the first line of defense and is conserved among all organisms (Parkin,
2001). A critical cell in the innate immune response is the neutrophil. Neutrophils are
phagocytic cells that migrate from the blood stream into infected tissues via chemotaxis.
Once inside tissues, neutrophils are able to recognize foreign material through pathogen
recognition receptors (PRRs) and the binding of pathogen associated molecular patterns
(PAMPs)(Akira et al. 2006). Upon recognition of viral material, neutrophils are able to
phagocytose and kill the invading pathogen via both oxygen dependent and independent
mechanisms. A key cellular pathway in cellular motility, phagocytosis, and microbial
killing is the phosphoinositide 3-kinase (PI3K) pathway. The key signaling molecule
generated by this pathway, phosphatidylinositol (3,4,5) triphosphate (PIP3), mediates
myriad cellular functions including protein synthesis, glucose metabolism, and actin
polymerization at the cell surface. The phosphatase, SHIP1 has been characterized as an
essential negative regulator of PIP3, inhibiting an overactive immune response and,
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preventing damage (Lam et al., 2012). In zebrafish, it has been revealed that upon an
influenza infection, SHIP1 is positively regulated, raising questions regarding the
influence that the virus has on the host’s machinery.
Due to issues accompanying the use of a variety of conventional animal models, and the
clear ethical concerns surrounding human testing, zebrafish are commonly employed as
models for human disease. Zebrafish are an established instrument for research into
development, genetics, cancer, immunity, and infection. Advantages of the zebrafish
versus its counterparts, the mouse (Mus musculus) and the fruit fly (Drosophila
melanogaster), are its short generation time, optical clarity, and its cellular and molecular
similarity to humans (Lieschke and Currie, 2007). The zebrafish genome is fully
sequenced and demonstrates high conservation between the human genome, making it a
useful model for human immunity and disease.
Previous studies have shown that the knockdown of the SHIP1 gene leads to increased
neutrophil migration, while overexpression of SHIP1 saw decreased neutrophil motility
(Lam et al.,2012). Viral infection led to an initial upregulation of SHIP1 in these studies.
SHIP1 may play an important role in neutrophil activity, specifically upon a viral
infection. Understanding the mechanisms behind neutrophil activity, particularly the role
of SHIP1, will aid in developing new and effective antiviral treatments.
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VIRUSES
Viruses are categorized as intracellular pathogens that are composed of proteins and
genetic information in
the form of either DNA
or RNA encompassed in
a capsid. In order for
the virus to replicate its
genetic information and
increase its
pathogenicity, it must
utilize host cell
enzymes and other
machinery (GarciaSastre and Biron, 2006).
	
  

When a virus comes

Fig. 1 Overview of viral infections in humans (Harvey et al., 2007)

into contact with a host
cell, it can insert its genetic information into the cell and then manipulate the host cell
machinery to replicate its genome and viral proteins. Upon accumulation of viral
proteins, the virus exits the cell to infect other cells, usually resulting in the death of the
host cell (Garcia-Sastre and Biron, 2006).
Viruses are prevalent throughout the world and are responsible for countless infections
and diseases (FIG.1). Over time, viruses have developed processes to evade the host
cells’ immune system, further increasing their pathogenicity. Understanding the
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processes by which viruses are able to evade the immune system will provide insights
into diagnosis, treatment, and elimination of viral diseases.

INFLUENZA VIRUS
Influenza, commonly known as the seasonal flu, is a virus that can infect many types of
animals including birds, horses, pigs, and humans and is characterized by seasonal
epidemics and pandemics (Schaechter et al 2013). In the United States, influenza ranks
among the major public
health threats, causing an
annual average of about 20
million respiratory illnesses,
100,000 hospitalizations, and
more than 20,000 deaths
(Schaechter et al 2013).
Influenza type A and B are
responsible for most
	
  

infections in humans.
Fig. 2 Structure of the influenza virus (Clancy. 2008)

Influenza enters the host
through inhaled airborne respiratory droplets that then infect the upper and lower
respiratory tract. Symptoms of an influenza virus are fever, headache, and overall
fatigue.
All influenza viruses contain eight negative sense, single stranded RNA segments
surrounded by the matrix (M) protein (Fig 2). Each RNA segment is encapsulated by the
viral nucleoprotein (NP) and the three virus-encoded polymerase proteins (PA, PB1, and
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PB2) (Schaechter et al 2013). The matrix protein is surrounded by a host-derived lipid
bilayer membrane with surface glycoproteins. The two glycoproteins, neuraminidase
(NA) and hemagglutinin (HA), undergo antigenic drift or antigenic shift resulting, in
changes in their composition. These changes allow the virus to evade the immune system
and persist in the respiratory tract. Influenza infection of cells begins with the binding of
HA to the sialic acid-containing glycolipid or glycoprotein viral receptors on the cell
surface. Upon attachment, the cell then engulfs the virus through an endocytic vesicle
(Schaechter et al 2013). The virus is then uncoated and its RNA segments are released
into the cytoplasm. The RNA enters the nucleus where mRNA is replicated, resulting in
the formation of new viral particles. The viral particles then exit the cell through lysis to
further infect other cells. This present study employs influenza as a model virus to
examine the immune system in these zebrafish.

ZEBRAFISH AS A MODEL ORGANISM
Due to ethical issues surrounding the use of biological testing on humans, animals have
been employed to research infectious diseases in the human. In vivo animal testing is
preferred over in vitro testing involving cell or tissue culture, as animals are complete
biological systems and their use can provide insight into the complex cellular
interactions, three-dimensional cellular geometry, and homeostatic regulation.
Biomedical research depends on the use of animal models to study to the pathologies of
human diseases at the cellular and molecular level (Lieschke and Currie 2007).
Mammals, such as the mouse (Mus musculus), have been successful models for human
disease as they have close genomic similarity as well as anatomy, cell biology and
physiology. However, due to financial and physical restrictions on the use of mammalian

6
	
  

models, invertebrate models have been preferred for genetic studies (Fig.3). Despite
their advantages, invertebrates lack organ systems similar to those that are involved in
human disease pathogenesis, thereby limiting their use in viral infection studies. This is
where the use of zebrafish
(Danio rerio), has come
into play.
Since 1930, zebrafish have
been employed as an
embryological and
developmental model
(Lieschke and Currie
2007). In the 1980s and
1990s, the development of
genetic techniques such as
cloning, mutagenesis,
transgenesis, and mapping
approaches established the
zebrafish as a standard for
developmental biology

	
  
Fig 3. While there are many advantages and disadvantages
to employing various model organisms for human diseases,
the zebrafish has been established as an excellent model
organism for human diseases (Liescke and Currie, 2007)

research. Zebrafish are vertebrate organisms that share striking anatomical and
physiological homologies with higher organism counterparts, while maintaining the
advantages of a lower organism (Goldsmith and Jobin 2012). Zebrafish have many
characteristics that make them useful for studying human pathologies. They are highly
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fecund with over 100 embryos per clutch, larvae that are functional for experiments 3
days after fertilization. Zebrafish are transparent up to 7 days after fertilization. They can
also be genetically manipulated, contain a genome that is fully mapped, and possess
organ and genetic homology to humans. Additional benefits include: external
fertilization (allowing access to the various developmental stages), short generation time
(3-4 months), egg size (0.7mm in diameter), and their short developmental period, i.e., all
major organs are developed within 36 hours of fertilization (Spence et al. 2008) (Fig 4).
Zebrafish possess an

fFIgd

innate immune system
comprised of neutrophils,
NK cells, and
monocyte/macrophage that
	
  
Fig	
  4. Image of the anatomy of the zebrafish taken using
brightfield microscopy 6 days post fertilization. Scale bar is
1mm. Benefits of using zebrafish are its small size and
transparency. (Goldsmith and Jobin, 2012)	
  

are functional at 48 hours
post fertilization
(Goldsmith and Jobin

2012). The innate immune system is functional at 2 days post fertilization, while the
adaptive immune system does not become fully functional until 4-6 weeks post
fertilization. This time difference allows for studies that involve the innate immune
system specifically. The adaptive immune system is highly analogous to that of
mammals, containing T cells and B cells, as well as a nearly complete set of Toll-Like
Receptors (TLRs) and associated innate signaling proteins, such as myeloid
differentiation primary response 88 (MyD88) and nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB) (Goldsmith and Jobin, 2012). Studies using
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zebrafish-human homolog genes of the immune system are made possible through the
constant updating of an online database containing extensive genomic information
(Goldsmith and Jobin, 2012).
One of the most important qualities of the zebrafish for research is its transparency. The
optically clear embryos allow real time imaging of critical cellular processes such as
phagocytosis and chemotaxis during an immune response. Using transgenic strains of
zebrafish that express fluorescently labeled immune cells or pathogens, in vivo imaging
of the interactions between the host and the pathogen is possible (Meijer and Spaink,
2011).
Although using zebrafish as a model for human pathologies has many advantages, there
are limitations to its uses. Because the use of zebrafish is relatively new, there are fewer
available strains compared to with the mouse model. Zebrafish also have numerous
duplicate genes, which complicates forward-reverse genetic manipulation (Goldsmith and
Jobin, 2012). The environmental conditions for maintaining zebrafish differ significantly
from those of humans. Zebrafish also require 28°C water containing specific ion
concentrations. These requirements present certain limitations to the use of zebrafish for
providing a complete representation of human biological processes.
To date, zebrafish have played a critical role in biomedical research. Zebrafish have been
shown to be susceptible to bacterial, protozoan, and viral infections, which is important
for modeling human diseases (Goldsmith and Jobin, 2012). At the University of Maine,
it has been shown that zebrafish can be infected with the gram negative bacterium,
Pseudomonas aeruginosa in Dr. Carol Kim’s Lab, the fungus Candida albicans in Dr.

9
	
  

Robert Wheeler’s Lab, and also the virus, Influenza also in Dr. Carol Kim’s Lab. These
discoveries provide the foundation for further biomedical research on human pathologies.

IMMUNITY
As stated earlier, zebrafish exhibit an immune system that is similar to that of humans.
Both branches of immunity, innate and adaptive, are present in the zebrafish, which
allows it serve as a model for human disease. More importantly, the adaptive immune
system is not developed until 4-6 weeks post fertilization, allowing studies that are
specific to the innate immune system (Goldsmith and Jobin, 2012).

	
  
Fig 5. Host immunity is composed of two components: innate immunity and adaptive immunity.
The innate immune response is first line of defense against infection, while adaptive immunity
provides a highly specific response, but takes longer to activate (Townsend et al., 2008).
	
  

The immune system is divided into 2 broad components: innate immunity and adaptive
immunity (Fig 5). In order for an organism to successfully recognize and eliminate a
pathogen, the two components must function properly. In order to function efficiently,
the host’s immune system must fulfill three requirements: (1) recognize a wide, but
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diverse array of pathogens, (2) rid the host of these pathogens once they are recognized
by the immune system, and (3) differentiate between self and non-self (Beutler et al.
2004). The interactive network responsible for facilitating the immune response is
comprised of lymphoid organs, cells, humoral factors, and cytokines. Improper
functioning of these components can result in an underactive or overactive immune
system, resulting in immunodeficiency, autoimmunity, or allergies (Parkin 2001).
The innate immune system is the host’s first line of defense against infections. It reacts
immediately to infection, with a comprehensive, broad range response that targets most
pathogens. There are physical and chemical barriers, such as the skin and mucous
membranes, and cellular components such as neutrophils, macrophages and natural killer
(NK) cells. The interaction of these mechanisms in the body with the invading microbes
often leads to a constellation of responses called inflammation (Schaechter et al. 2013).
The innate immune response is present among all metazoan, plant, invertebrate, and
vertebrate organisms. Vertebrate animals, such as humans and zebrafish, developed a
second line of defense called adaptive immunity.
While the innate immune system employs genetically encoded receptors that detect and
recognize foreign materials, the adaptive immune system uses a different subset of
leukocytes called lymphocytes. This elite set of leukocytes known as B-cells and T-cells
have the capacity to generate a large number of antigen-specific cell surface receptors by
random rearrangement (Schaechter et al. 2013). Despite taking days or weeks to develop,
the adaptive immune system is able to clear the pathogen as well as generate
immunologic memory. Creating immunologic memory allows the host immune system
to elicit a rapid and specialized response when encountering the same pathogen in the
11
	
  

future (Bonilla and Oettgen, 2009). Although the adaptive immune response is more
effective at eliminating specific pathogens, its activation requires signaling from the
innate immune system.
The immune system is able to discriminate between foreign pathogens and harmless
microbes through the use of pattern recognition receptors (PRRs). One family of PRRs is
called toll-like receptors (TLRs). TLRs recognize many essential microbial molecules,
including essential cellular components such as lipopolysaccharide, lipoproteins,
lipoteichoic, peptidoglycan, flagella, bacterial DNA, fungal cell walls, and viral RNA
(Schaechter et al. 2013). For example, in the case of an influenza infection, TLR7 and
TLR8 recognize single stranded viral RNA, activating viral inhibitory proteins, MyD88
and NF-κB, as well as interferons to activate macrophages and NK cells.
Of all the innate antimicrobial defenses in the body, the most potent is the cellular
response which consists of neutrophils, eosinophils, and monocytes into infected tissues
(Schaechter et al. 2013). Neutrophils are phagocytic cells that are recruited to the site of
infection and are crucial for a proper immune response. In order for neutrophils to be
effective, they must first migrate to the site of infection. Infected or damaged tissues and
other immune cells elicit cytokines that attract neutrophils. Cytokines are small secreted
proteins that play a crucial role in the interaction and communication between cells. Cell
surface receptors on neutrophils allow for the detection of chemical gradients from
cytokines guiding them to the site of infection via chemotaxis.
Once neutrophils have migrated from the blood stream into tissues they recognize foreign
pathogens through surface receptors such as TLRs, C-type lectin receptors, and
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nucleotide-binding oligomerization protein 1 (NOD1) (Mantovani et al. 2011). Early
signaling events, such as the phosphorylation of phosphatidylinositol 4,5-bisphosphate
(PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3) through the PI3K pathway
induce polymerization of actin and remodeling of the localized membrane, which is
essential for particle ingestion (Lee et al. 2003). After engulfing the pathogen, the
neutrophil develops machinery that is necessary to kill it. To eradicate the pathogen, the
neutrophil employs contents of intracellular granules. The largest of these, the
azurophilic granules contain various antimicrobial substances to kill invading pathogens.
Azurophil-type granules contain peptides such as α-defensin and phospholipase A2, and
enzymes such as lysozyme, elastase, and myeloperoxidase enzymes, which produce
hypochlorous acid (HOCl) and Cl- to kill the pathogen. Specific-type granules contain
peptides such as cathelicidin and lactoferrin, and enzymes such as lysozyme and NADPH
oxidase, which are used to eradicate the pathogen (Schaechter et al. 2013). Once the
microbe is killed, the phagolysosomes accumulate in the cytoplasm and the neutrophil
eventually lyses and the resulting debris are phagocytosed by macrophages.
Neutrophils play a critical role in the immune response. It has been demonstrated that
neutrophils also act as an important bridge between the innate and adaptive immune
response as they are important mediators of T helper cells and activators of B cells
(Mantovani et al. 2011). Organisms that suffer from congenital or acquired defects in
neutrophil life cycle and function can experience chronic infections and other life
threatening conditions, demonstrating the importance of the neutrophil in the immune
response.
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PI3K SIGNALING PATHWAY
Neutrophils are vital to an effective immune response. Upon exposure to inflammatory
signals neutrophils perform several specialized functions including chemotaxis,
phagocytosis, and microbial killing (Moraes and Downey, 2003). In order to be
successful in eradicating invading pathogens neutrophils rely on the
phosphatidylinositide 3-kinase (PI3K) pathway. Phosphatidylinositide 3-kinases are a
group of enzymes that convert plasma membrane phosphatidylinositol-4,5-biphosphate
(PIP2), to phosphatidylinositol-3,4,5-trisphosphate (PIP3) upon exposure to signals in the
form of growth factors, chemokines, and cytokines on the cell surface. PIP3 is the key
messenger in the PI3K signaling pathway. Formation of PIP3 initiates numerous cellular
functions such as phagocytosis, chemotaxis, microbial killing, and apoptosis through
activation of numerous other pathways (FIG 6). If the PI3K pathway is overactive,
resulting in the overproduction of PIP3, immune cells can produce a detrimental immune
response which leads to excessive inflammation and damage of tissues. To control the
level of PIP3, phosphatases PTEN and SHIP1 degrade PIP3 to its inactive form, PIP2. It
is well established that in neutrophils, chemoattractant signaling via G protein-coupled
receptors induces an increase in the PIP3/PIP2 ratio at the leading edge during
chemotaxis in vivo (Yoo et al., 2010). Activation of PI3K results in rapid polarized Factin polymerization, which is crucial for cellular motility (Barberis and Hirsch, 2008).
Without the key PIP3 molecule, immune cells cannot migrate to the site of infection and
perform specialized functions such as phagocytosis, microbial killing, and apoptosis
(Moraes and Downey, 2003).
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The PI3K family of enzymes is divided into 3 classes, I, II and III, according to their
primary structure and substrate specificity (Moraes and Downey, 2003). Class II and III
kinases are expressed
in all cells, but their
mechanisms of action
are not well
understood. Class I
kinases are further
divided into two
subgroups, IA and IB.
	
  
Fig 6. Overview of the PI3K signaling pathway. The key signaling
molecule PIP3 which is produced via this pathway mediates various
cell functions such as protein synthesis, cell motility, and
phagocytosis (Moraes and Downey, 2003).

The catalytic subunit,
p110 has four
recognized isoforms:

p110-α, β, δ, in class IA and γ in class IB. Class IA p110 subunits are activated
predominantly by receptor tyrosine kinases (RTK). P110α and β are ubiquitously
expressed in tissues while p110δ and γ of class IB are primarily found in leukocytes
(Moraes and Downey, 2003).
The PI3K pathway is initiated by the activation of the PI3-kinase enzymes. Through
receptor tyrosine kinases (RTKs), integrins, B and T cell receptors, cytokine receptors, Gprotein-coupled receptors and many others. Binding of extracellular growth factors to
plasma membrane-bound RTK results in dimerization and autophosphorylation.
Dimerization and autophosphorylization at the tyrosine residues allows the RTKs to
interact with SH2 domain containing molecules, such as SHIP1 phosphatases (Castellano
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and Downard, 2011). Lipid kinase PI3K is then recruited to the plasma membrane
binding site and PI3K is activated. PI3K then converts membrane bound PIP2 to its
active form, PIP3. PIP3 drives various downstream pathways such as Akt, Rac, and Arf6
to regulate numerous cellular functions such as cell migration, phagocytosis, cell survival
and microbial killing. These cytosolic proteins have pleckstrin homology (PH) domains
that bind to PIP3, leading to their activation (Moraes and Downey, 2003). Numerous
studies have shown that in neutrophils, the PI3K pathway plays a central role in
endothelial adhesion and transmigration into infected tissues, chemotaxis, phagocytosis,
microbial killing, and apoptosis (Moraes and Downey, 2003).

AKT/PKB PATHWAY
The serine/threonine kinase, Akt/PKB, and its isoforms consist of a conserved domain
structure: an amino terminal pleckstrin homology (PH) domain, a central kinase domain,
and a carboxyl-terminal regulatory domain (Song et al. 2005). The PH domain of the
protein kinases interacts with PIP3 that is produced by PI3-kinase. All Akt isoforms have
two regulatory phosphorylation sites, Thr308 in the activation loop within the kinase
domain and Ser473 in the C-terminal regulatory domain. Activation of Akt requires a
PI3-kinase and a PH domain translocation, as well as phosphorylation of both sites (Song
et al. 2005). While phosphorylation of the Thr308 site partially activates Akt/PKB, full
activation requires phosphorylation of both sites. The PH domain is required for the
recruitment of Akt/PKB to the plasma membrane through the high affinity binding to
PIP3 (Song et al. 2005). PIP3 does not activate Akt/PKB, but instead recruits it to the
plasma membrane to be phosphorylated by the phospho-inositide-dependent kinase-1
(PDK1). Once at the plasma membrane, Akt/PKB is phosphorylated at two specific sites,
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Thr308 and Ser473. Thr308 is the main site for phosphorylation, which is accomplished
by PKB. Less is known about the phosphorylation of Ser473 but there is evidence
suggesting that it can be auto phosphorylated or phosphorylated by the integrin-linked
kinase (Song et al. 2005). The phosphorylated Akt/PKB can then go on to activate
transcription factors, proteins and other signaling pathways that control apoptosis, cell
growth, and glucose metabolism.

RAC PATHWAY
Other PH domain-containing
proteins that are activated by PIP3
include guanosine diphosphate
(GDP)-GTP exchange factors for
Rac proteins (Cantley et al. 2002).
Rac proteins are a subfamily of the
Rho family of monomeric GTPases
and are responsible for multiple
	
  

cellular functions such as cell
adhesion, transcriptional and
translational activation, protein

Fig 7. The Rac pathway is activated by PIP3 via
their PH domain-containing proteins. Once
activated, Rac GTPases are responsible for cell
adhesion, protein synthesis and other cell functions
(Cantley et al., 2002).

synthesis, as well as formation of
reactive oxygen species by NADPH oxidase complex in neutrophils which is crucial for
microbial killing (Welch et al. 2003). Rac proteins are molecular switches that are
inactive when GDP is bound and active when bound to GTP (Fig 7). Rac-GDP
complexes are attached to the membrane through its C-terminal prenylation, exposing
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them to the activating enzyme, a guanine-nucleotide exchange factor, GEF (Welch et al.
2003). GEF is able to expose the nucleotide binding site of the GTPase, which facilitates
the dissociation of GDP and binding of GTP, which is present at high concentrations in
the cytosol of the cell. Rac activation can be accomplished in both PI3K-dependent and
PI3K-independent pathways through the activation of GEF, but a large number of RacGEF families can be activated directly by PIP3. Once Rac proteins are activated, they
can bind to their target proteins which are crucial to myriad functions in the cell.

ARF6 PATHWAY
The ADP-ribosylation factors (Arfs)
belong to a family of Ras-related
GTP-binding proteins. Much like
Rac proteins, Arfs alternate between
the inactive GDP-bound complex and
the active, GTP-bound complex.
Arf6 has been the subject of recent
	
  

studies because of its effects on
membrane trafficking and actin
cytoskeleton at the plasma membrane

Fig 8. Arf6 are activated by PIP3 through their
PH domain. Activation of Arf proteins results in
the remodeling of cytoskeleton actin, changing
cell shape (Donaldson, 2003).

(Donaldson, 2003). Arf6 activation is
facilitated by guanine nucleotide exchange factors (GEFs), which allows the binding of
GTP. While it is well understood that Arf6 plays a significant role in control of the actin
cytoskeleton to affect the cell shape, it also is required for cell migration (Fig 8). Arf6
has been recently shown to be crucial in leukocyte chemokine-stimulated migration
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across epithelial cells (Donaldson, 2003). Actin cytoskeleton restructuring and cellular
migration are key components to an effective immune response.

SHIP1
The SHIP1 phosphatase enzyme serves as a negative regulator of the key signaling
molecule, phosphatidylinositol (3,4,5) triphosophate. SHIP enzymes contain 1190 amino
acids, have a molecular mass of 133kD, and contain several motifs that are important for
protein-protein
interactions
	
  

(Rohrschneider et
al. 2000). The
central amino acid

Fig 9. This is the SHIP1 gene containing SH2 domain, the two
NPXY domains, and the multiple PxxP binding domains
(Rohrschneider et al. 2000).

domain contains genetic information for the enzymatic activity of the SHIP enzyme,
while the carboxy-terminal domain encodes two NPXY motifs and multiple PxxP motifs,
and the SH2 domain is found at the N-terminus (Fig 9). Upon tyrosine phosphorylation
of NPXY motifs, proteins with a phosphotyrosine binding (PTB) domain, like the tensin
proteins, are able to interact with SHIP at these sites. Phosphorylation of the NPXY
motifs also provides potential interaction sites for SH2 domain-containing proteins
(Rohrschneider et al. 2000). Several PxxP motifs are present on the carboxyl terminus
and can serve as binding sites for proteins containing SH3 domains. Together, these
structural features comprise a unique and important protein that has enzymatic and
signaling properties. SHIP is expressed in almost all cells of the bone marrow and blood
cells express at least one form of the SHIP protein (Rohrschneider et al. 2000). SHIP
mRNA has been found at the earliest stages of hematopoietic cell development in mouse
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embryos and protein expression has been detected in all blood cell lineages including
macrophages and granulocytes. SHIP homologues, SHIP1 and SHIP2 are expressed in all
mammals, with SHIP1 expression limited to the hematopoietic lineage and while SHIP2
is expressed broadly (Lam et al 2012). Zebrafish express one copy of SHIP1 and two
copies of SHIP2: SHIP2a and SHIP2b. The central enzymatic domain of SHIP proteins
has been identified by its similarity to inositol phosphates. This domain is highly
conserved (96% identical) between murine and human SHIP proteins. SHIP enzymes
remove the phosphate group from the 5’ position on both phosphatidylinositol 3,4,5 –
triphosphate [PI(3,4,5)P3] and 1,3,4,5-tetrakisphosphates (IP4) (Rohrschneider et al.
2000). The 3’ position of the inositol phospholipid must be phosphorylated before SHIP1
can act on it, suggesting that SHIP acts sequentially with phosphatidylinositol 3 kinases
(PI3K). PI3K, which contains a 85-kD regulatory subunit and a 110-kD catalytic subunit,
is responsible for PIP3 production. The p85 subunit of PI3K contains two SH2 domains,
which are
recognized by
the p85 SH-2
domain in SHIP
proteins. This
p85/PI3K
association with
SHIP could
represent an interesting complex of enzymes that convert PI(4,5)P2 to the key signaling
molecule, PI(3,4,5)P3, then finally to PI(3,4)P2. The PI(3,4)P2/ PI(3,4,5)P3
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accumulation at the leading edge of neutrophils in vitro inspired research into the role of
SHIP phosphatases during neutrophil motility in vivo. This work showed that in
zebrafish, both SHIP1 and SHIP2 promptly localize to the leading edge and occasionally
the tail of migrating neutrophils. Deletion of SHIP1 increased neutrophil migration while
overexpression inhibited neutrophil motility (Lam et al. 2012). Since PI3K activity and
leading edge PI(3,4,5)P3 is required for neutrophil motility in vivo (Yoo et al. 2010), it is
suggested that SHIP1 hydrolyzes the key signaling molecule PI(3,4,5)P3 into PI(3,4)P2
in neutrophils, thereby limiting their motility. It has also been suggested that SHIP1 acts
as a key brake in neutrophil migration to prevent a damaging, over active immune
response via a PI3K signaling pathway.

MORPHOLINO OLIGONUCEOTIDES (MO)
Gene manipulation has long been a tool used in genetic research and developmental
biology. Forward genetics focuses on the study of a specific phenotype and determination
of the genetic basis for that phenotype (Lieschke and Currie, 2007). Reverse genetics
allows for the study of the biological function of a gene by altering the expression of that
gene during development and observing the effects.
The most widely used reverse genetics antisense technique in zebrafish involves
morpholino oligonucleotides (MO), which are employed for gene knockdown. MOs are
synthetic oligonucleotides composed of 25 morpholine bases [O(CH2CH2)2NH] bound by
a neutrally charged phosphorodiamidate backbone (Bill et al, 2009). Although similar in
structure to DNA and RNA oligomers, MO oligomers are neutrally charged; making
them more stable in the cellular environment and the altered backbone allows them to
resist degradation by circulating endogenous endonucleases. Most importantly, the
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morpholine bases can still participate in Watson-Crick base pairing allowing MOs to bind
to specific cellular RNA sequences (Ekker and Akimenko, 2010). Developed by Dr.
James Summerton, MOs were first designed to inhibit translation of mRNA in vivo.
There are two types of MOs: splice blocking and translational blocking morpholinos (Fig
11). Splice
blocking MOs
inhibit the function
of the spliceosome,
a protein complex
that removes
introns from premRNA (Bill et al,
2009).
Translational
blocking MOs bind
to complementary
mRNA sequences
Fig 11. Gene knockdown technique employing MOs. (A) Structure of
MOs, which is similar to DNA and RNA oligomers. (B,C,D) Splice
blocking MO technique and (E,F) shows translational blocking MO
mechanism (Bill et al., 2009).

within the 5’
untranslated region
(UTR) which

inhibits ribosome assembly, hence obstructing translation. Procedures such as reverse
transcription polymerase chain reaction (RT-PCR) can quantify the efficacy of a splice
blocking MO, whereas a western blot assay can measure the efficacy of translation
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blocking MOs. Typically, MOs are introduced into zebrafish embryos at the 1-8-cellstage, allowing rapid, comprehensive delivery through the early embryonic cells (Bill et
al, 2009).
Although the use of MOs is beneficial for genetic research, it is a relatively new practice
and certain constraints should be recognized. First, in smaller embryos the repeated
injection of specific volumes of MOs can be a source of error. Inconsistent MO
administration among embryos can result in unreliable gene expression (Eisen and Smith,
2008). Second, MO injection can affect off-target genes. The MO can interfere with
production of irrelevant gene products, thereby introducing the possibility that the newly
observed phenotype is not the result of the targeted gene knockdown. The last concern is
the administration of the control. The most reliable control is to attempt to “rescue” the
phenotype by introducing the gene product of interest in a form that is unaffected by the
MO (Eisen and Smith, 2008). An effective rescue technique is to inject mRNA at the 1cell stage. In the case of a translational blocking MO, removing the 5’ UTR of the
mRNA or introducing silent mutations into the coding region should rescue the
phenotype (Eisen and Smith, 2008). With a splice-blocking MO, injecting mRNA can
also have the ability to rescue the phenotype (Eisen and Smith, 2008). The use of MO
knockdowns and other genetic manipulation techniques have allowed research into gene
identification, gene function, and the verification of specific mutant phenotypes (Bill et
al., 2009).
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MATERIALS AND METHODS
Zebrafish Maintenance, Antisense Morpholino Injection, Viral Injection, and
Mortality:
Zebrafish Maintenance. Zebrafish embryos were held in 75 mL of egg water (60 mg/L of
Instant Ocean, Spectrum Brands, Madison, WI) at 28°C. Once the embryos were injected
with virus, zebrafish larvae were held at 33°C in the same egg water solution.
Antisense Morpholino Injection. Zebrafish embryos were injected with an antisense
morpholino oligonucleotide at the 1 cell stage (0.5 to 1 hours post fertilization). One
SHIP1 splice-blocking morpholino (SHIP1 MO) was injected at 250 µM per embryo in a
3 nL injection. The control MO was injected at the same concentration and volume. The
SHIP1 MO was designed using Gene Tools, LLC (Table 1).
Morpholino

Sequence (5’ – 3’)

SHIP1 MO

ATG ACT TAA GAC ATC TCA CCC
ATG T

Control

CCT CTT ACC TCA GTT ACA ATT
ATA A

Table 1 The SHIP1 morpholino sequence, designed by Gene Tools (Philomath, OR), was
injected at the 1 cell stage.
Mopholino efficiency was tested using RT-PCR. After MO was injected, 6 fish were
isolated at 1, 2, and 3 days post fertilization (dpf) for each treatment (control and SHIP1KD). After injection of MO, the expression of SHIP1 was expected to be greatly reduced,
or knock down (SHIP1-KD). RNA was extracted using the Trizol protocol (Ambion) and
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cDNA was then synthesized using the iScript protocol. For PCR, the PCR MasterMix
was used with the 2x kit protocol (Promega #9P1M750) with the following primers:
Primer

Sequence (5’-3’)

SHIP1 Forward

GTC TCC TGG AGC TGG AAG
ACT AAG

SHIP1 Reverse

GTC ATG TGG GAT TTG AGG
GGC TGT G

The products were then analyzed on a 1% agarose gel. 10µL of PCR product was then
loaded with 2µL of 6x Orange G dye.

	
  
[ Ladder ][

LANE 1

][

LANE 2

][

LANE 3

][ Ladder ]

Fig 12 Agarose gel results demonstrate that the SHIP1 MO at the concentration that was used
efficiently knocked SHIP1 down through 3dpf. Shifted bands represent an exon skip caused
by the MO interaction. Gel setup: 1dpf – 2dpf – 3dpf with ladder on each end.

Viral Injection. For survival studies: at 48 hpf, embryos were dechorionated with forceps
and anesthetized in tricaine. Influenza A/PR/8/34 (H1N1, EID50 109.6) virus (Charles
River, North Franklin, CT) was injected into the tail vein to elicit a systemic infection in
both SHIP1 morphant and control embryos. Two, 2 nL injections were administered per
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embryo with 12,720 Embryo Infective Dose, EID50 per fish. This is amount of virus
particles required to infect 50% of the zebrafish. The virus injection contained 8 µL of
virus stock, 0.5 µL of 5% phenol red, and 1.5 µL Hanks Balanced Salt Solution (HBSS).
The control injection contained 9.5 µL HBSS and 0.5 µL of 5% phenol red solution.
For qPCR (Injection performed by Denise Jurczyszak of the Kim Lab): Charles River
Stock EID50 1010.3/mL, an influenza virus stock was used in this experiment. 2 nL were
injected into the tail vein of the zebrafish (12,500 EID50/embryo) to elicit a systemic
immune response.
Mortality. Embryos injected with control or IAV were kept in 50 mL of egg water
throughout the experiment. At 8 hours post infection (hpi), deceased embryos were
removed and surviving embryos were counted. This represented the count at Day 0. At
this stage, all deceased embryos were attributed to incidental trauma from injection rather
than from IAV. In 24 hour intervals, surviving embryos were counted through 5 days
and egg water was changed upon each counting.
RNA Extraction, cDNA Synthesis, qPCR, and Respiratory Burst Assay:
RNA Extraction. Embryos from SHIP1-morphant and control zebrafish were collected at
12, 24, 48, 72, 96, and 120 hpi. Five zebrafish were used per replicate and three
replicates were done for each treatment at each time point. RNA was extracted using the
Trizol protocol (Ambion). To quantify the RNA extracted, a NanoDrop
spectrophotometer was used.
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cDNA Synthesis. cDNA was synthesized from the extracted RNA from each treatment
and time points, using the iScript cDNA synthesis kit (BioRad, Hercules, CA). The
samples were the diluted to 50 ng/µL with nuclease free water.
qPCR. For a total of 10 uL per qPCR reaction, each reaction contained 5uL of SoFast
EvaGreen mastermix (BioRad, Hercules, CA) or Quanta Green FastMix (Quanta,
Gaithersburg, MD) as the fluorescent dye, 0.2 µL of forward/reverse target gene primer
(0.2 µM final concentration) and 2uL of cDNA (10 ng/µL final concentration). 2.8 µL of
nuclease free water was also added to bring the volume up to 10 µL. Quantification cycle
(Cq) values were calculated using a CFX96 real-time detection system. Analysis of these
Cq values was then completed in GraphPad Prism 6.
Primer

Sequence (5’-3’)

SHIP1 Forward

GGC ACT TGG AAC ATG GGA AA

SHIP1 Reverse

CCT CCT GTG TCC CGA TTA CG

18s Forward

TCG CTA GTT GGC ATC GTT TAT G

18s Reverse

CGG AGG TTC GAA GAC GAT CA

Table 2 The SHIP1 forward/reverse primers were added during qPCR measurements.
The 18s forward and reverse primers were used as the control. Primers were
designed by Gene Tools (Philomath, OR). Primers are designed to bind to the
SHIP1 DNA sequence during the annealing phase, resulting in amplification of
the SHIP1 gene to determine its relative expression.
Respiratory Burst Assay (RBA). Zebrafish embryos were injected with MO as previously
described. The RBA was the performed at 3 dpf as described in (Goody et al., 2013) with the exception that the plate was not shaken immediately after adding phorbol
myristate acetate (PMA), instead it was placed directly into a 28°C incubator. The PMA
was added along with the fluorescent molecule, H2DCFDA, to the zebrafish. The PMA
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involves the activation of protein kinase C (PKC) which induces a respiratory burst of
phagocytes. Upon respiratory burst, the reactive oxygen species (ROS) that are produced
inside the phagocyte react with the fluorescent molecule H2DCFDA. This reaction
oxidizes H2DCFDA, causing it to fluoresce. The intensity of the fluorescence correlates
to the amount of ROS produced within the phagocyte.
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RESULTS
SHIP1 is upregulated upon infection by influenza A virus. To test the expression of
SHIP1 in zebrafish during a viral infection, both control and SHIP1-KD zebrafish were
injected with either influenza A virus or HBSS control. At various time points, RNA was
extracted and then synthesized into cDNA. Real time qPCR was used to measure the
levels of SHIP1. Upon infection, SHIP1 is upregulated within the first 24 hpi until
120hpi. Statistical significance was found at 24, 72, 96, and 120hpi (Fig 13). SHIP1 is a
negative regulator of neutrophil activity, thereby decreasing the immune response. qPCR
data show that SHIP1 is upregulated during the time frame during which the immune
response would be strongest, suggesting that the influenza virus is able to manipulate
SHIP1 expression, allowing the virus to evade the immune response.
	
  
	
  

Fig 13. Relative expression profiles of SHIP1 in zebrafish after IAV infection. At various time
points it can be seen that SHIP1 is upregulated upon IAV infection. Both graphs represent separate
experiments and with one injection performed by Campbell Miller and the other performed by
Denise Jurcyzsak, both of the Kim Lab.
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SHIP1 plays a critital role in zebrafish survival during an IAV infection. To
determine whether SHIP1 has a role in the innate immune response to a viral infection,
H1N1 IAV was injected into 48 hpf, SHIP1-KD zebrafish. Every 24 hours, the number
of surviving zebrafish was determined and the precent survival was calculated over the
span of 5 days. At this early stage in development, only the innate immune system is
present in zebrafish larvae and is responsible for clearing the viral infection. As
anticipated, IAV infection in control zebrafish resulted in decreased percent survival. In
SHIP1-KD zebrafish, however, IAV infection resulted in greater percent survival,
suggesting that SHIP1 plays a role in the zebrafish innate immune response (Fig 14).

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

	
  

Fig 15. Percent survival curves of control and SHIP1-KD zebrafish that were injected with
either HBSS control or IAV. The graph demonstrates that compared to control zebrafish
	
  
infected with IAV, SHIP1-KD zebrafish infected with IAV has a greater percent survival
	
  
isercent
statistically
significant.
Fig	
  that
14.	
  P
survival
curves of control and SHIP1-KD zebrafish that were injected with
	
  

	
   either HBSS control or IAV. The graph demonstrates that compared to control zebrafish
infected with IAV, SHIP1-KD zebrafish infected with IAV has a greater percent survival that is
	
   statistically significant. Ct indicates zebrafish injected with control MO, while KD indicates
zebrafish injected with SHIP1 MO. These fish were then infected with IAV or HBSS. 	
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SHIP1 plays a role in reactive oxygen species (ROS) production. Having established
that SHIP1 is upregulated during an IAV infection and plays a role in the zebrafish
antiviral immune response, it was of interest to explore its function in phagocyte activity.
A respiratory burst assay was performed to determine the role of SHIP1 in ROS
production in phagocytic cells. SHIP1-KD and control zebrafish at 3dpf, were loaded
onto microplates and PMA was added to induce a respiratory burst. It was determined
that SHIP1-KD zebrafish produced fewer relative fluorescence units (RFU) compared to
control fish, indicating fewer ROS species were produced (Fig 15). This data
demonstrates that SHIP1 plays a critical role in ROS production.
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

	
  
	
  

Fig 15. Respiratory burst assay (RBA) results of control and SHIP1-KD
zebrafish. Results of the RBA demonstrate fewer RFU in SHIP-KD zebrafish
compared to controls, indicating that SHIP1 plays a role in ROS production
and microbial killing.
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DISCUSSION
Viruses are common throughout the world and cause numerous diseases. We are
interested in studying the innate immune system as it pertains to specific viral infections.
Using zebrafish as model organisms, these studies provide insight into a variety of
pathways and mechanisms that contribute to viral pathology. Understanding these
mechanisms can contribute to the development of treatments for viral infections among
humans. The gene SHIP1 has yet to be characterized specifically during a viral infection,
yet its role in the innate immune system during a wound response has been researched
widely. In the current study, the role of SHIP1 during an innate immune response to an
influenza virus infection was investigated in vivo using zebrafish.
Previous studies revealed that SHIP1 is upregulated during an influenza infection
in zebrafish (Campbell Miller, unpublished results). SHIP1 enzymes act as negative
regulators of neutrophil motility, possibly to prevent damage from an overactive immune
response. More specifically, SHIP1 phosphatases degrade the key signaling molecule	
  
phosphatidylinositol (3,4,5) triphosphate (PIP3) at the plasma membrane to
phosphatidylinositol (3,4) diphosphate (PIP2) in the phosphoinositide 3-kinase (PI3K)
pathway. Neutrophils rely on the PI3K signaling pathway to induce chemotaxis,
phagocytosis of pathogens, and microbial killing. These data suggest that the virus causes
upregulation of SHIP1, allowing it to evade the host innate immune response. SHIP1
expression during a viral infection was established and so further research was performed
to identify other effects SHIP1 might have during the antiviral innate immune response.
First, the role of SHIP1 in overall zebrafish survival was examined during an
influenza infection. SHIP1 MO was administered to zebrafish embryos at the one cell
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stage in order to knock down SHIP1 expression. The SHIP1-KD zebrafish and control
zebrafish were then injected in the tail vein with HBSS control solution or IAV 48hpf to
result in a systemic infection. As expected, the control zebrafish infected with IAV had a
decreased percent survival (Fig 14). However, SHIP1-KD zebrafish had an increased
percent survival, similar to that of control zebrafish injected with HBSS control solution.
These data support the notion that the expression of SHIP1 during a viral infection is
possibly mediated by the virus rather than the host to evade the immune response and
cause further damage. Knock down of SHIP1 led to increased survival indicating that
increased SHIP1 expression during a viral infection, which was established by previous
qPCR data (Fig 13), leads to decreased survival among IAV infected zebrafish.
A respiratory burst assay (RBA) was then performed to determine the effect of
SHIP1 on production of reactive oxygen species (ROS). ROS are chemically reactive
molecules which are present in phagocytes and are responsible for microbial killing.
RBA results demonstrated that SHIP1-KD zebrafish exhibited less fluorescence (relative
fluorescent units - RFU) compared to control zebrafish. These data indicate that SHIP1KD zebrafish produced lower levels of ROS compared to control zebrafish. These
results suggest that SHIP1 plays a role in microbial killing through the production of
ROS. Although upregulation of SHIP1results in higher levels of ROS, and subsequently
more pathogen killing, this could have a damaging effect as well. Elevated levels of
ROS, and their release upon phagocyte apoptosis, can damage host epithelial cells.
During a viral infection, the upregulation of SHIP1 causes an increase in the production
of ROS which, could further damage the host and be, in part, responsible for the
decreased percentages survival values (Fig 14).
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The data presented are consistent with the hypothesis that SHIP1 plays a critical
role in the innate immune system during an influenza infection. Although SHIP1 serves
as a negative regulator of neutrophil motility to prevent an over active immune response,
aberrant and increased expression of SHIP1 during an influenza infection, can lead to
increased host damage, decreased survival, and decreased ROS production., Further
research is needed to fully characterize the role of SHIP1in the innate immune response
as this could lead to the development of antiviral treatments, especially those directed
toward influenza infections.	
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